Biotalys is developing a new generation of protein-based biocontrol solutions. Euronext: BTLS.
Biotalys develops innovative formulations of crop protection products based on Agrobodies (antibody fragments from camel antibodies). These products can be used at lower dosages or have a longer lasting effect without repeat applications and thereby contribute to improved and more sustainable agricultural production. The company is a spin-off of the Vrije Universiteit Brussel and VIB.
Spica Therapeutics is pioneering Macrophage-Subset targeted therapies
THERAtRAME develops and positions new therapeutics targeting tRNA epitranscriptomics in cancer.
Sentea leverages silicon photonics to develop a cost-effective fiber optic sensor interrogator.
